223 related articles for article (PubMed ID: 9826445)
1. Long-term analysis of allergen-specific T cell clones from patients with asthma treated with allergen rush immunotherapy.
Oda N; Yamashita N; Minoguchi K; Takeno M; Kaneko S; Sakane T; Adachi M
Cell Immunol; 1998 Nov; 190(1):43-50. PubMed ID: 9826445
[TBL] [Abstract][Full Text] [Related]
2. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
[TBL] [Abstract][Full Text] [Related]
3. Human gammadelta T cells modulate the mite allergen-specific T-helper type 2-skewed immunity.
Korematsu S; Tanaka Y; Nagakura T; Minato N; Izumi T
Clin Exp Allergy; 2007 Nov; 37(11):1681-7. PubMed ID: 17883427
[TBL] [Abstract][Full Text] [Related]
4. Altered T cell ligands derived from a major house dust mite allergen enhance IFN-gamma but not IL-4 production by human CD4+ T cells.
Tsitoura DC; Verhoef A; Gelder CM; O'Hehir RE; Lamb JR
J Immunol; 1996 Sep; 157(5):2160-5. PubMed ID: 8757342
[TBL] [Abstract][Full Text] [Related]
5. House dust mite immunotherapy results in a decrease in Der p 2-specific IFN-gamma and IL-4 expression by circulating T lymphocytes.
O'Brien RM; Byron KA; Varigos GA; Thomas WR
Clin Exp Allergy; 1997 Jan; 27(1):46-51. PubMed ID: 9117880
[TBL] [Abstract][Full Text] [Related]
6. Peptide specificity and HLA restriction do not dictate lymphokine production by allergen-specific T-lymphocyte clones.
van Neerven RJ; van de Pol MM; Wierenga EA; Aalberse RC; Jansen HM; Kapsenberg ML
Immunology; 1994 Jul; 82(3):351-6. PubMed ID: 7525459
[TBL] [Abstract][Full Text] [Related]
7. Induced apoptosis of TH2 lymphocytes in asthmatic children treated with Dermatophagoides pteronyssinus immunotherapy.
Tsai YG; Chien JW; Chen WL; Shieh JJ; Lin CY
Pediatr Allergy Immunol; 2005 Nov; 16(7):602-8. PubMed ID: 16238586
[TBL] [Abstract][Full Text] [Related]
8. Insufficient increment of CD4+CD25+ regulatory T cells after stimulation in vitro with allergen in allergic asthma.
Wang LH; Lin YH; Yang J; Guo W
Int Arch Allergy Immunol; 2009; 148(3):199-210. PubMed ID: 18849611
[TBL] [Abstract][Full Text] [Related]
9. [Effects of Dermatophagoides pteronyssinus allergen-specific immunotherapy on the prognosis of asthmatic children].
Chen ZG; Chen YF; Li M; Ji JZ; Chen FH; Chen H
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jun; 29(6):1179-81. PubMed ID: 19726355
[TBL] [Abstract][Full Text] [Related]
10. Altered beta2-adrenergic regulation of T cell activity after allergen challenge in asthma.
Heijink IH; van den Berge M; Vellenga E; de Monchy JG; Postma DS; Kauffman HF
Clin Exp Allergy; 2004 Sep; 34(9):1356-63. PubMed ID: 15347367
[TBL] [Abstract][Full Text] [Related]
11. Intranasal IL-12 produces discreet pulmonary and systemic effects on allergic inflammation and airway reactivity.
Matsuse H; Kong X; Hu J; Wolf SF; Lockey RF; Mohapatra SS
Int Immunopharmacol; 2003 Apr; 3(4):457-68. PubMed ID: 12689651
[TBL] [Abstract][Full Text] [Related]
12. T-cell cytokine pattern at three time points during specific immunotherapy for mite-sensitive asthma.
Majori M; Caminati A; Corradi M; Brianti E; Scarpa S; Pesci A
Clin Exp Allergy; 2000 Mar; 30(3):341-7. PubMed ID: 10691891
[TBL] [Abstract][Full Text] [Related]
13. Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration.
Antúnez C; Mayorga C; Corzo JL; Jurado A; Torres MJ
Pediatr Allergy Immunol; 2008 May; 19(3):210-8. PubMed ID: 18399897
[TBL] [Abstract][Full Text] [Related]
14. Rush immunotherapy in an experimental model of feline allergic asthma.
Reinero CR; Byerly JR; Berghaus RD; Berghaus LJ; Schelegle ES; Hyde DM; Gershwin LJ
Vet Immunol Immunopathol; 2006 Mar; 110(1-2):141-53. PubMed ID: 16325921
[TBL] [Abstract][Full Text] [Related]
15. Skin tests, T cell responses and self-reported symptoms in children with allergic rhinitis and asthma due to house dust mite allergy.
Moed H; van Wijk RG; de Jongste JC; van der Wouden JC
Clin Exp Allergy; 2009 Feb; 39(2):222-7. PubMed ID: 19032359
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of fluvastatin on cytokine and chemokine production by peripheral blood mononuclear cells in patients with allergic asthma.
Samson KT; Minoguchi K; Tanaka A; Oda N; Yokoe T; Yamamoto Y; Yamamoto M; Ohta S; Adachi M
Clin Exp Allergy; 2006 Apr; 36(4):475-82. PubMed ID: 16630152
[TBL] [Abstract][Full Text] [Related]
17. Rush immunotherapy results in allergen-specific alterations in lymphocyte function and interferon-gamma production in CD4+ T cells.
Lack G; Nelson HS; Amran D; Oshiba A; Jung T; Bradley KL; Giclas PC; Gelfand EW
J Allergy Clin Immunol; 1997 Apr; 99(4):530-8. PubMed ID: 9111499
[TBL] [Abstract][Full Text] [Related]
18. IL-2-induced IL-9 production by allergen-specific human helper T-cell clones.
Kajiyama Y; Umezu-Goto M; Kobayashi N; Takahashi K; Fukuchi Y; Mori A
Int Arch Allergy Immunol; 2007; 143 Suppl 1():71-5. PubMed ID: 17541281
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of preferential induction of mite-specific T helper 0 clones.
Yamashita N; Takeno M; Kaneko S; Mizushima Y; Sakane T
Clin Exp Immunol; 1997 Aug; 109(2):332-41. PubMed ID: 9276530
[TBL] [Abstract][Full Text] [Related]
20. Different profile of CD8+ effector T cells induced in Der p 1-allergic and naïve mice by DNA vaccination.
Draghi M; Jarman ER; Grifantini R; Galli-Stampino L; Lamb JR; Valiante NM; Grandi G
Eur J Immunol; 2002 Dec; 32(12):3720-8. PubMed ID: 12516566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
